Easterly Investment Partners LLC raised its holdings in shares of Delek US Holdings, Inc. (NYSE:DK - Free Report) by 2.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 765,249 shares of the oil and gas company's stock after buying an additional 21,210 shares during the period. Delek US comprises 1.1% of Easterly Investment Partners LLC's investment portfolio, making the stock its 21st largest position. Easterly Investment Partners LLC owned 1.21% of Delek US worth $14,157,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Sei Investments Co. lifted its holdings in shares of Delek US by 2.3% during the 4th quarter. Sei Investments Co. now owns 52,595 shares of the oil and gas company's stock valued at $973,000 after acquiring an additional 1,192 shares in the last quarter. Orion Portfolio Solutions LLC lifted its stake in shares of Delek US by 7.6% during the third quarter. Orion Portfolio Solutions LLC now owns 18,254 shares of the oil and gas company's stock worth $342,000 after purchasing an additional 1,292 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Delek US by 8.1% in the fourth quarter. PNC Financial Services Group Inc. now owns 19,500 shares of the oil and gas company's stock valued at $361,000 after buying an additional 1,464 shares in the last quarter. KBC Group NV raised its holdings in shares of Delek US by 66.3% during the 4th quarter. KBC Group NV now owns 3,859 shares of the oil and gas company's stock valued at $71,000 after buying an additional 1,538 shares during the period. Finally, Swiss National Bank lifted its position in Delek US by 1.3% during the 4th quarter. Swiss National Bank now owns 126,891 shares of the oil and gas company's stock worth $2,347,000 after acquiring an additional 1,600 shares in the last quarter. 97.01% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Delek US
In other Delek US news, CFO Mark Wayne Hobbs bought 2,800 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The shares were acquired at an average cost of $13.70 per share, for a total transaction of $38,360.00. Following the acquisition, the chief financial officer now directly owns 49,138 shares of the company's stock, valued at $673,190.60. This trade represents a 6.04 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. In the last ninety days, insiders bought 5,055 shares of company stock valued at $70,787. 1.80% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on the stock. Wolfe Research raised shares of Delek US from an "underperform" rating to a "peer perform" rating in a report on Friday, January 3rd. Morgan Stanley reduced their price objective on shares of Delek US from $19.00 to $18.00 and set an "underweight" rating on the stock in a research note on Friday, March 14th. JPMorgan Chase & Co. lifted their price target on Delek US from $21.00 to $22.00 and gave the stock a "neutral" rating in a research note on Tuesday, December 10th. Piper Sandler dropped their price target on Delek US from $18.00 to $17.00 and set a "neutral" rating on the stock in a research report on Friday, March 7th. Finally, Mizuho decreased their price objective on shares of Delek US from $26.00 to $25.00 and set a "neutral" rating for the company in a report on Monday, December 16th. Five analysts have rated the stock with a sell rating and six have given a hold rating to the stock. According to MarketBeat, Delek US currently has a consensus rating of "Hold" and an average price target of $20.40.
View Our Latest Analysis on DK
Delek US Stock Performance
Shares of NYSE:DK traded down $0.35 during trading hours on Monday, hitting $15.30. The stock had a trading volume of 263,315 shares, compared to its average volume of 1,176,886. The stock's fifty day simple moving average is $17.03 and its 200 day simple moving average is $17.84. The firm has a market capitalization of $956.45 million, a price-to-earnings ratio of -3.14 and a beta of 1.14. The company has a debt-to-equity ratio of 3.18, a quick ratio of 0.67 and a current ratio of 1.04. Delek US Holdings, Inc. has a 1-year low of $13.40 and a 1-year high of $33.60.
Delek US (NYSE:DK - Get Free Report) last released its earnings results on Tuesday, February 25th. The oil and gas company reported ($2.54) EPS for the quarter, missing the consensus estimate of ($1.53) by ($1.01). The company had revenue of $2.37 billion for the quarter, compared to analyst estimates of $2.58 billion. Delek US had a negative net margin of 2.27% and a negative return on equity of 28.21%. The firm's quarterly revenue was down 39.8% on a year-over-year basis. During the same period in the previous year, the business posted ($1.46) EPS. Sell-side analysts anticipate that Delek US Holdings, Inc. will post -5.5 earnings per share for the current fiscal year.
Delek US Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, March 10th. Shareholders of record on Monday, March 3rd were paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 6.67%. The ex-dividend date was Monday, March 3rd. Delek US's payout ratio is currently -11.54%.
About Delek US
(
Free Report)
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
Featured Stories

Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.